Total Payments
$12,297
2024 Payments
$1,978
Companies
38
Transactions
540
Medicare Patients
13,499
Medicare Billing
$2.1M
Payment Breakdown by Category
Food & Beverage$12,277 (99.8%)
Education$20.14 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,277 | 538 | 99.8% |
| Education | $20.14 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,387 | 93 | $0 (2024) |
| Amgen Inc. | $1,303 | 71 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,266 | 61 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,264 | 55 | $0 (2024) |
| Abbott Laboratories | $1,069 | 19 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $944.49 | 46 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $781.95 | 33 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $687.96 | 24 | $0 (2024) |
| PFIZER INC. | $590.68 | 30 | $0 (2024) |
| Merck Sharp & Dohme LLC | $498.92 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,978 | 77 | AstraZeneca Pharmaceuticals LP ($294.30) |
| 2023 | $1,403 | 68 | Merck Sharp & Dohme LLC ($215.10) |
| 2022 | $1,441 | 71 | Janssen Pharmaceuticals, Inc ($272.97) |
| 2021 | $1,627 | 72 | Janssen Pharmaceuticals, Inc ($233.23) |
| 2020 | $1,074 | 49 | Amgen Inc. ($202.76) |
| 2019 | $1,246 | 54 | Amgen Inc. ($197.92) |
| 2018 | $1,708 | 67 | SANOFI-AVENTIS U.S. LLC ($298.86) |
| 2017 | $1,821 | 82 | Novartis Pharmaceuticals Corporation ($438.86) |
All Payment Transactions
540 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.68 | General |
| Category: DIABETES | ||||||
| 12/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: VACCINES | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.06 | General |
| Category: Cardiovascular | ||||||
| 12/09/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: VACCINES | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $9.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $5.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.15 | General |
| Category: Cardiovascular | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $5.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $7.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.42 | General |
| Category: DIABETES | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/12/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $2.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/28/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Cardiology | ||||||
| 08/15/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Pacemakers | ||||||
| 08/07/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.11 | General |
| Category: Cardiovascular | ||||||
| 08/07/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $4.47 | General |
| Category: Cardiovascular | ||||||
| 07/24/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $22.98 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 3,833 | 6,321 | $2.2M | $578,933 |
| 2022 | 25 | 3,500 | 5,780 | $1.9M | $542,720 |
| 2021 | 27 | 3,363 | 5,286 | $1.8M | $517,313 |
| 2020 | 26 | 2,803 | 4,450 | $1.5M | $414,095 |
Total Patients
13,499
Total Services
21,837
Medicare Billing
$2.1M
Procedure Codes
103
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 572 | 1,394 | $278,800 | $154,067 | 55.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 552 | 564 | $563,400 | $102,699 | 18.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 407 | 410 | $328,000 | $76,537 | 23.3% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 69 | 69 | $103,500 | $57,029 | 55.1% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 222 | 222 | $222,000 | $39,358 | 17.7% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 94 | 94 | $94,000 | $20,481 | 21.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 681 | 1,484 | $126,140 | $19,396 | 15.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 181 | 252 | $37,800 | $19,171 | 50.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 104 | 104 | $31,200 | $15,705 | 50.3% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 23 | 212 | $74,200 | $13,846 | 18.7% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 58 | 60 | $54,000 | $11,071 | 20.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 40 | 49 | $12,150 | $7,565 | 62.3% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 83 | 86 | $30,100 | $5,503 | 18.3% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 41 | 68 | $11,560 | $4,916 | 42.5% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 94 | 94 | $47,000 | $4,579 | 9.7% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 59 | 194 | $19,400 | $4,080 | 21.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 33 | 34 | $8,500 | $3,899 | 45.9% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 42 | 141 | $14,100 | $3,676 | 26.1% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 18 | 167 | $25,050 | $3,650 | 14.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 252 | 377 | $5,655 | $3,155 | 55.8% |
| 93976 | Ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 16 | 16 | $8,000 | $2,230 | 27.9% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 94 | 94 | $32,900 | $2,139 | 6.5% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 17 | 55 | $5,500 | $1,710 | 31.1% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 67 | 67 | $13,400 | $1,598 | 11.9% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 14 | 14 | $7,000 | $873.21 | 12.5% |
About Dr. Nir Somekh, M.D
Dr. Nir Somekh, M.D is a Internal Medicine healthcare provider based in Great Neck, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/28/2008. The National Provider Identifier (NPI) number assigned to this provider is 1053579953.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nir Somekh, M.D has received a total of $12,297 in payments from pharmaceutical and medical device companies, with $1,978 received in 2024. These payments were reported across 540 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($12,277).
As a Medicare-enrolled provider, Somekh has provided services to 13,499 Medicare beneficiaries, totaling 21,837 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease
- Location Great Neck, NY
- Active Since 05/28/2008
- Last Updated 05/02/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053579953
Products in Payments
- XARELTO (Drug) $1,264
- ENTRESTO (Drug) $1,154
- ELIQUIS (Drug) $1,133
- FARXIGA (Drug) $750.95
- JARDIANCE (Drug) $637.60
- Repatha (Biological) $617.19
- Corlanor (Drug) $560.43
- BRILINTA (Drug) $515.38
- VERQUVO (Drug) $498.92
- PRALUENT (Drug) $442.95
- MULTAQ (Drug) $339.00
- LEQVIO (Drug) $233.03
- CRT-Ps (Device) $224.26
- Quadra Assura CRT Defibrillator (Device) $196.18
- AVEIR (Device) $192.19
- Vascepa (Drug) $188.07
- Optimizer Smart System (Device) $161.85
- TELEPATCH CARDIAC MONITOR (Device) $152.30
- Assurity Pacemaker (Device) $152.07
- WATCHMAN (Device) $147.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Great Neck
Dr. Jamie Hirsch, Md, MD
Internal Medicine — Payments: $69,165
Internal Medicine $69,165
Joanne Lee, M.d, M.D
Internal Medicine — Payments: $36,469
Internal Medicine $36,469
Bernard Rosof
Internal Medicine — Payments: $26,679
Internal Medicine $26,679
Dr. Shahram Shamekh, Md, MD
Internal Medicine — Payments: $18,187
Internal Medicine $18,187
Sanford Ratner, M.d, M.D
Internal Medicine — Payments: $16,933
Internal Medicine $16,933
David Edelson, Md, MD
Internal Medicine — Payments: $15,163
Internal Medicine $15,163